Temporal analysis of enhancers during mouse cerebellar development reveals dynamic and novel regulatory functions

Abstract

We have identified active enhancers in the mouse cerebellum at embryonic and postnatal stages which provides a view of novel enhancers active during cerebellar development. The majority of cerebellar enhancers have dynamic activity between embryonic and postnatal development. Cerebellar enhancers were enriched for neural transcription factor binding sites with temporally specific expression. Putative gene targets displayed spatially restricted expression patterns, indicating cell-type specific expression regulation. Functional analysis of target genes indicated that enhancers regulate processes spanning several developmental epochs such as specification, differentiation and maturation. We use these analyses to discover one novel regulator and one novel marker of cerebellar development: Bhlhe22 and Pax3, respectively. We identified an enrichment of de novo mutations and variants associated with autism spectrum disorder in cerebellar enhancers. Furthermore, by comparing our data with relevant brain development ENCODE histone profiles and cerebellar single-cell datasets we have been able to generalize and expand on the presented analyses, respectively. We have made the results of our analyses available online in the Developing Mouse Cerebellum Enhancer Atlas (https://goldowitzlab.shinyapps.io/developing_mouse_cerebellum_enhancer_atlas/), where our dataset can be efficiently queried, curated and exported by the scientific community to facilitate future research efforts. Our study provides a valuable resource for studying the dynamics of gene expression regulation by enhancers in the developing cerebellum and delivers a rich dataset of novel gene-enhancer associations providing a basis for future in-depth studies in the cerebellum.

Data availability

Sequencing data have been deposited in GEO under accession code: GSE183697

The following data sets were generated
The following previously published data sets were used

Article and author information

Author details

  1. Miguel Ramirez

    Centre for Molecular Medicine and Therapeutics, British Columbia Children's Hospital, Vancouver, Canada
    Competing interests
    The authors declare that no competing interests exist.
  2. Yuliya Badayeva

    Centre for Molecular Medicine and Therapeutics, British Columbia Children's Hospital, Vancouver, Canada
    Competing interests
    The authors declare that no competing interests exist.
  3. Joanna Yeung

    Centre for Molecular Medicine and Therapeutics, British Columbia Children's Hospital, Vancouver, Canada
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-0551-5305
  4. Joshua Wu

    Centre for Molecular Medicine and Therapeutics, British Columbia Children's Hospital, Vancouver, Canada
    Competing interests
    The authors declare that no competing interests exist.
  5. Ayasha Abdalla-Wyse

    Centre for Molecular Medicine and Therapeutics, British Columbia Children's Hospital, Vancouver, Canada
    Competing interests
    The authors declare that no competing interests exist.
  6. Erin Yang

    Centre for Molecular Medicine and Therapeutics, British Columbia Children's Hospital, Vancouver, Canada
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-5629-2362
  7. FANTOM 5 Consortium

    Department of Molecular Genetics, Hospital for Sick Children, Toronto, Canada
  8. Brett Trost

    The Centre for Applied Genomics, Hospital for Sick Children, Toronto, Canada
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-4863-7273
  9. Stephen W Scherer

    Department of Molecular Genetics, Hospital for Sick Children, Toronto, Canada
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-8326-1999
  10. Daniel Goldowitz

    Centre for Molecular Medicine and Therapeutics, British Columbia Children's Hospital, Vancouver, Canada
    For correspondence
    dang@cmmt.ubc.ca
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-4756-4017

Funding

NSERC Discovery Award

  • Daniel Goldowitz

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: All studies were conducted according to the protocols approved by the Institutional Animal Care and Use Committee and the Canadian Council on Animal Care at the University of British Columbia.

Copyright

© 2022, Ramirez et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Miguel Ramirez
  2. Yuliya Badayeva
  3. Joanna Yeung
  4. Joshua Wu
  5. Ayasha Abdalla-Wyse
  6. Erin Yang
  7. FANTOM 5 Consortium
  8. Brett Trost
  9. Stephen W Scherer
  10. Daniel Goldowitz
(2022)
Temporal analysis of enhancers during mouse cerebellar development reveals dynamic and novel regulatory functions
eLife 11:e74207.
https://doi.org/10.7554/eLife.74207

Share this article

https://doi.org/10.7554/eLife.74207

Further reading

    1. Developmental Biology
    Yan-Xue Li, Xin-Le Kang ... Xiao-Fan Zhao
    Research Article

    Juvenile hormone (JH) is important to maintain insect larval status; however, its cell membrane receptor has not been identified. Using the lepidopteran insect Helicoverpa armigera (cotton bollworm), a serious agricultural pest, as a model, we determined that receptor tyrosine kinases (RTKs) cadherin 96ca (CAD96CA) and fibroblast growth factor receptor homologue (FGFR1) function as JH cell membrane receptors by their roles in JH-regulated gene expression, larval status maintaining, rapid intracellular calcium increase, phosphorylation of JH intracellular receptor MET1 and cofactor Taiman, and high affinity to JH III. Gene knockout of Cad96ca and Fgfr1 by CRISPR/Cas9 in embryo and knockdown in various insect cells, and overexpression of CAD96CA and FGFR1 in mammalian HEK-293T cells all supported CAD96CA and FGFR1 transmitting JH signal as JH cell membrane receptors.

    1. Developmental Biology
    2. Neuroscience
    Mahima Bose, Ishita Talwar ... Shubha Tole
    Research Article

    In the developing vertebrate central nervous system, neurons and glia typically arise sequentially from common progenitors. Here, we report that the transcription factor Forkhead Box G1 (Foxg1) regulates gliogenesis in the mouse neocortex via distinct cell-autonomous roles in progenitors and postmitotic neurons that regulate different aspects of the gliogenic FGF signalling pathway. We demonstrate that loss of Foxg1 in cortical progenitors at neurogenic stages causes premature astrogliogenesis. We identify a novel FOXG1 target, the pro-gliogenic FGF pathway component Fgfr3, which is suppressed by FOXG1 cell-autonomously to maintain neurogenesis. Furthermore, FOXG1 can also suppress premature astrogliogenesis triggered by the augmentation of FGF signalling. We identify a second novel function of FOXG1 in regulating the expression of gliogenic cues in newborn neocortical upper-layer neurons. Loss of FOXG1 in postmitotic neurons non-autonomously enhances gliogenesis in the progenitors via FGF signalling. These results fit well with the model that newborn neurons secrete cues that trigger progenitors to produce the next wave of cell types, astrocytes. If FGF signalling is attenuated in Foxg1 null progenitors, they progress to oligodendrocyte production. Therefore, loss of FOXG1 transitions the progenitor to a gliogenic state, producing either astrocytes or oligodendrocytes depending on FGF signalling levels. Our results uncover how FOXG1 integrates extrinsic signalling via the FGF pathway to regulate the sequential generation of neurons, astrocytes, and oligodendrocytes in the cerebral cortex.